Data / Form D filings / Kellbenx Inc.
Kellbenx Inc.: Form D filings
Kellbenx Inc., a biotechnology company in Great River, NY, filed 10 Form D notices with the SEC between 2011 and 2023. The latest, on June 28, 2023, reports an offering of $2.5 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3500 SUNRISE HIGHWAY, BUILDING 200, SUITE 111, Great River, NY, 11739
- Phone
- (631) 812-2103
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1515776
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 28, 2023 | New notice | $2,500,000 | $0 | $2,500,000 | 0 | Yet to occur | sec.gov |
| Nov 10, 2020 | New notice | $1,200,000 | $0 | $1,200,000 | 0 | Yet to occur | sec.gov |
| Oct 18, 2019 | Amendment | $3,750,000 | $2,550,000 | $1,200,000 | 20 | Dec 14, 2017 | sec.gov |
| Dec 7, 2015 | New notice | $3,300,000 | $3,211,000 | $89,000 | 9 | Dec 4, 2015 | sec.gov |
| May 12, 2015 | New notice | $3,100,000 | $0 | $3,100,000 | 3 | Apr 29, 2015 | sec.gov |
| Jul 19, 2013 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
| Oct 24, 2012 | New notice | $500,000 | $500,000 | 0 | Oct 22, 2012 | sec.gov | |
| Feb 29, 2012 | New notice | $1,000,000 | $1,000,000 | 8 | Feb 28, 2012 | sec.gov | |
| Apr 18, 2011 | New notice | $1,350,000 | $1,350,000 | 8 | Apr 14, 2011 | sec.gov | |
| Mar 22, 2011 | New notice | $1,075,000 | $1,075,000 | 1 | Mar 11, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Mashaal | Director | |
| Thomas Auth | Director | |
| Leonard Kellner | Director | |
| Ethan Benovitz | Director | |
| Hassan Bennani | Executive Officer, Director | |
| Daniel Saks | Director | |
| Jeffrey Lightcap | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Jun 26, 2023 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kellbenx Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.